Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects

Clinical trial NCT06062680 · UNKNOWN

Trial details

NCT number: NCT06062680
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Adult Patients With Chronic Primary ITP Adult Patients With SAA Who do Not Respond Well to Immunosuppressive Therapy

Start date: 2023-10-01
Primary completion: 2023-11-15
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.